| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 7 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 | |
| #3 | United States | 4 | |
| #4 | Canada | 3 | |
| #5 | Singapore | 3 | |
| #6 | Israel | 2 | |
| #7 | Australia | 1 | |
| #8 | China | 1 | |
| #9 | Japan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Measuring microorganism processes | |
| #3 | Peptides | |
| #4 | Medical preparations | |
| #5 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Thirion Christian | 24 |
| #2 | Ruzsics Zsolt | 10 |
| #3 | Koszinowski Ulrich | 7 |
| #4 | Langer Simona | 6 |
| #5 | Höfig Ines | 4 |
| #6 | Anastasov Natasa | 3 |
| #7 | Schrödel Silke | 1 |
| #8 | Anastasov Nataša | 1 |
| #9 | Anastasov Nata{Hacek Over (S)}A | 1 |
| #10 | Christian Thirion | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020115114A1 | Viral transduction using poloxamines | |
| AU2017213170A1 | AAV-based conditional expression system | |
| WO2015104376A1 | Pseudotyped lentiviral vectors | |
| WO2014006146A1 | Means and methods to increase adenovirus production | |
| EP2566957A2 | Vaccine against beta-herpesvirus infection and use thereof | |
| EP2471909A1 | Nucleic acid molecules for generating adenoviral vectors |